Burned To A Crisper

 | Dec 19, 2018 12:20PM ET

Crispr Therapeutics (NASDAQ:CRSP) is involved in the kind of technology that promises to enable genetic programming. Horrible as this prospect is, I was more intrigued by the bearish stock pattern, which is unfolding beautifully. This thing looks like a straight-up two-headed catastrophe.